[Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO].
The paper summarises updated knowledge concerning use of rHuEPO in patients with non-renal anemia. Taking into consideration hematological and clinical effects as well as improvement of general well-being obtained after EPO treatment, administration of this hormone is an essential extension of indication for this type of patients.
Dyjas
R
R
Katedry i Kliniki Nefrologii Slaskiej Akademii Medycznej, Katowicach.
Wiecek
A
A
Kokot
F
F
D000740:Anemia / Q000628:therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin